Corbus Pharmaceuticals Holdings, Inc. Letters of Credit Outstanding, Amount
Corbus Pharmaceuticals Holdings, Inc. (CRBP) had Letters of Credit Outstanding, Amount of $13.73 thousand as of 2016-06-30, per its 10-Q filed 2016-08-12.
Discontinued › Notes › Other Liabilities
us-gaap:LettersOfCreditOutstandingAmount · last filed 2017-03-08
- 2016-06-30: Letters of Credit Outstanding, Amount $13.73K.
- 2016-03-31: Letters of Credit Outstanding, Amount $13.73K.
- 2015-12-31: Letters of Credit Outstanding, Amount $13.73K.
- 2015-09-30: Letters of Credit Outstanding, Amount $13.73K.
| Period end | Letters of Credit Outstanding, Amount | Letters of Credit Outstanding, Amount as first filed |
|---|---|---|
| 2016-06-30 | $13.73K 10-Q · filed 2016-08-12 | |
| 2016-03-31 | $13.73K 10-Q · filed 2016-05-13 | |
| 2015-12-31 | $13.73K 10-K · filed 2016-03-28 | |
| 2015-09-30 | $13.73K 10-Q · filed 2015-11-10 | |
| 2015-06-30 | $13.73K 10-Q · filed 2015-08-13 | |
| 2015-03-31 | $13.73K 10-Q · filed 2015-05-13 | |
| 2014-12-31 | $13.73K 10-K · filed 2015-02-10 | |
| 2014-09-30 | $13.72K 10-Q · filed 2014-11-13 | |
| 2014-07-01 | $13.73K 10-K · filed 2017-03-08 | $13.72K 10-Q · filed 2016-11-10 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Annexon, Inc. (ANNX) | United States | $0.147B | -4.22 |
| SPRUCE BIOSCIENCES, INC. (SPRB) | United States | $0.142B | -2.89 |
| Korro Bio, Inc. (KRRO) | United States | $0.141B | -1.81 |
| Atrium Therapeutics, Inc. (RNA) | United States | $0.140B | |
| Curanex Pharmaceuticals Inc (CURX) | United States | $0.138B | |
| TuHURA Biosciences, Inc./NV (HURA) | United States | $0.134B | -4.88 |
| Unicycive Therapeutics, Inc. (UNCY) | United States | $0.134B | -3.70 |
| NRX Pharmaceuticals, Inc. (NRXP) | United States | $0.131B | -6.31 |
| MEDICINOVA INC (MNOV) | United States | $0.130B | -6.04 |
| IMMUNIC, INC. (IMUX) | United States | $0.127B | -1.88 |